Sort   by:  
 Page size 
GenomicsNext Generation Sequencing facilitates to identify the differential expression genes between tumor (T1-8) and non-tumor tissue (NT1-8) from HBV-infected hepatocellular cacinoma (HCC) patients.
Next Generation Sequencing facilitates to identify the differential expression genes between tumor (T1-8) and non-tumor tissue (NT1-8) from HBV-infected hepatocellular cacinoma (HCC) patients.
PRJNA858039 | ENA
TranscriptomicsNext Generation Sequencing facilitates to identify the differential expression genes between tumor (T1-8) and non-tumor tissue (NT1-8) from HBV-infected hepatocellular cacinoma (HCC) patients.
To find the key gene regulating HBV-infected hepacellular cacinoma genesis and development. We selected tumor (T1-8) and non-tumor tissue (NT1-8) from HBV-infected hepatocellular cacinoma (HCC) patients perform next-generation sequencing (NGS). Illumina mRNA-seq sample preparation kit was used to pe...
ORGANISM(S): Homo sapiens 
2024-11-30 | GSE208036 | GEO
UnknownTranscriptome analysis identifies metallothionein as biomarkers to predict recurrence in hepatocellular cacinoma.
Not available
S-EPMC6565558 | biostudies-literature
GenomicsTo identify the differential expression of aGalcer/IL-2 treated T cells (iNKT) from human peripheral blood mononuclear cells of healthy donors (HD), chronic hepatitis B (CHB) and HBV-infected hepatocellular cacinoma (HCC) patients
To identify the differential expression of aGalcer/IL-2 treated T cells (iNKT) from human peripheral blood mononuclear cells of healthy donors (HD), chronic hepatitis B (CHB) and HBV-infected hepatocellular cacinoma (HCC) patients
PRJNA858049 | ENA
ProteomicsIron response of HepG2 cells - The exon-intron gene structure upstream of the initiation codon predicts translation efficiency
Quantitative proteomics of HepG2 cells in response to iron. SILAC 3plex was conducted
ORGANISM(S): Homo sapiens (Human) 
2018-04-23 | PXD006661 | Pride
Human Lc-ms/ms Hepatocellular cacinoma Iron 
TranscriptomicsTo identify the differential expression of aGalcer/IL-2 treated T cells (iNKT) from human peripheral blood mononuclear cells of healthy donors (HD), chronic hepatitis B (CHB) and HBV-infected hepatocellular cacinoma (HCC) patients
To identify the different status of iNKT cells treated by aGalcer/IL-2 from CHB and HCC patients compared to HD. We enriched α-GalCer/IL-2 expanded iNKT cells from healthy donors (HD iNKT), CHB patients (CHB iNKT), and HBV-infected HCC patients (HCC iNKT) to rperforme next-generation sequencing (NGS...
ORGANISM(S): Homo sapiens 
2025-07-11 | GSE208038 | GEO
Sort   by:  
 Page size